Organization
Daehwa Pharmaceutical
4 clinical trials
Clinical trial
A Multinational, Multicenter, Open-label, Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of Liporaxel® (Oral Paclitaxel) Compared to Taxol® (IV Paclitaxel) as First-line Therapy in Patients With Recurrent or Metastatic HER2 Negative Breast CancerStatus: Active (not recruiting), Estimated PCD: 2024-01-30
Clinical trial
A Multi-national,Multi-center, Open-label, Phase 2 Clinical Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of DHP107 (Liporaxel®,Oral Paclitaxel) Compared to IV Paclitaxel in Patients With Recurrent or Metastatic Breast Cancer(OPERA)Status: Completed, Estimated PCD: 2022-12-13
Clinical trial
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Drug-drug Interaction of DHP2302R1 and DHP2302R2 in Healthy Adult VolunteersStatus: Active (not recruiting), Estimated PCD: 2024-07-19
Clinical trial
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Drug-drug Interactions Between DHP2306R1 and DHP2306R2 in Healthy Adult VolunteersStatus: Active (not recruiting), Estimated PCD: 2024-04-01